1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, July 2012 (p50)

Drug Discovery and Development Analysis & Statistics, July 2012 (p50)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

1471-1500 of about 1 600 reports

Purchase Reports From Reputable Market Research Publishers

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

  • $ 3 500
  • Industry report
  • July 2012
  • by GBI Research

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies Summary GBI Research, the ...

  • Industries : Drug Discovery and Development
  • Countries : World
Global High Content Screening (HCS) Industry

Global High Content Screening (HCS) Industry

  • $ 4 450
  • Industry report
  • July 2012
  • by Global Industry Analysts

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual ...

  • Industries : Drug Discovery and Development
  • Countries : World
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles Summary GBI Research in its report “Endpoints - ...

  • Industries : Pathology
  • Countries : World
Indian Bioinformatics Market Forecast to 2015

Indian Bioinformatics Market Forecast to 2015

  • $ 500
  • Industry report
  • May 2012
  • by RNCOS

Bioinformatics is one of the fastest emerging interdisciplinary research areas, which may be defined as an ‘interface between biological and computational sciences’. Most of the Bioinformatics work ...

  • Industries : Drug Discovery and Development
  • Countries : India
Triple Analysis: Leukemia, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Leukemia, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Lung Cancer, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Lung Cancer, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Lymphoma, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Lymphoma, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug and Medication
Triple Analysis: Leukemia, Pancreatic Cancer and Protein Kinase Inhibitors

Triple Analysis: Leukemia, Pancreatic Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, General Medicine and Specialty Medicine
Triple Analysis: Colorectal Cancer, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Colorectal Cancer, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Apoptosis, Angiogenesis and Protein Kinase Inhibitors. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, Pharmaceutical, Therapy
Triple Analysis: Colorectal Cancer, Leukemia and Protein Kinase Inhibitors

Triple Analysis: Colorectal Cancer, Leukemia and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Leukemia and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, General Medicine and Specialty Medicine
Triple Analysis: Colorectal Cancer, Lung Cancer and Protein Kinase Inhibitors

Triple Analysis: Colorectal Cancer, Lung Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug and Medication
Triple Analysis: Colorectal Cancer, Lymphoma and Protein Kinase Inhibitors

Triple Analysis: Colorectal Cancer, Lymphoma and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug and Medication
Triple Analysis: Colorectal Cancer, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Colorectal Cancer, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Leukemia, Lung Cancer and Protein Kinase Inhibitors

Triple Analysis: Leukemia, Lung Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, General Medicine and Specialty Medicine
Triple Analysis: Leukemia, Lymphoma and Protein Kinase Inhibitors

Triple Analysis: Leukemia, Lymphoma and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, General Medicine and Specialty Medicine
Triple Analysis: Leukemia, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Leukemia, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Lung Cancer, Lymphoma and Protein Kinase Inhibitors

Triple Analysis: Lung Cancer, Lymphoma and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug and Medication
Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Lymphoma, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Lymphoma, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical
Triple Analysis: Lymphoma, Pancreatic Cancer and Protein Kinase Inhibitors

Triple Analysis: Lymphoma, Pancreatic Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug and Medication
Triple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Triple Analysis: Pancreatic Cancer, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Pancreatic Cancer, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Therapy, Drug Discovery and Development
Global Clinical Trial Management Systems (CTMS) Industry

Global Clinical Trial Management Systems (CTMS) Industry

  • $ 4 200
  • Industry report
  • April 2012
  • by Global Industry Analysts

This report analyzes the worldwide markets for Clinical Trial Management Systems (CTMS) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of ...

  • Industries : Drug Discovery and Development
  • Countries : World
Bioinformatics Market Outlook to 2015

Bioinformatics Market Outlook to 2015

  • $ 1 200
  • Industry report
  • March 2012
  • by RNCOS

During the past decade, the bioinformatics market has significantly evolved across the globe on back of rising genomics industry. The increasing application of genomics in biotech and pharmaceutical research ...

  • Industries : Drug Discovery and Development, Genomics
  • Countries : World
Triple Analysis: Colorectal Cancer, Leukemia and Pancreatic Cancer

Triple Analysis: Colorectal Cancer, Leukemia and Pancreatic Cancer

  • $ 5 175
  • Company report
  • March 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Leukemia and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical
Triple Analysis: Colorectal Cancer, Lung Cancer and Pancreatic Cancer

Triple Analysis: Colorectal Cancer, Lung Cancer and Pancreatic Cancer

  • $ 5 175
  • Company report
  • March 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lung Cancer and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Triple Analysis: Colorectal Cancer, Lymphoma and Pancreatic Cancer

Triple Analysis: Colorectal Cancer, Lymphoma and Pancreatic Cancer

  • $ 5 175
  • Company report
  • March 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lymphoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.